Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Total 13F shares
-
56,103,335
-
Share change
-
+2,467,751
-
Total reported value
-
$646,305,236
-
Put/Call ratio
-
30%
-
Price per share
-
$11.52
-
Number of holders
-
114
-
Value change
-
+$34,182,922
-
Number of buys
-
58
-
Number of sells
-
48
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2019
As of 31 Dec 2019,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,103,335 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, BlackRock Inc., ORBIMED ADVISORS LLC, Sonic Fund II, L.P., STATE STREET CORP, UBS Group AG, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.